BeiGene, Ltd. (BGNE) has 20 known insider and institutional holders on record. The largest holder is HILLHOUSE INVESTMENT MANAGEMENT, LTD. with 147,043,058 shares. Other notable holders include HHLR ADVISORS, LTD. and AMGEN INC.
Over the last 12 months, insiders have made 10 transactions in BGNE stock — 7 buys (valued at $2.48M) and 2 sells (valued at $136.19K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
BGNE Insider Ownership
Top Holder
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
147,043,058 shares
Buys (12 mo)
7
$2.48M value
Sells (12 mo)
2
$136.19K value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Hillhouse Investment Management, Ltd. |
Director |
147,043,058 |
2022-08-24 |
|
| 2 |
Hhlr Advisors, Ltd. |
10 Percent Owner |
125,045,741 |
2024-12-04 |
|
| 3 |
Amgen Inc |
10 Percent Owner |
18,943,802 |
2021-09-13 |
|
| 4 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
5,082,165 |
2025-03-13 |
|
| 5 |
Wang Lai |
Global Head of R&d |
990,171 |
2025-03-07 |
|
| 6 |
Baker Bros. Advisors Lp |
Director |
791,493 |
2024-12-10 |
|
| 7 |
Wang Julia Aijun |
Chief Financial Officer |
256,659 |
2024-06-07 |
|
| 8 |
Lee Chan Henry |
SVP, General Counsel |
246,142 |
2025-03-07 |
|
| 9 |
Rosenberg Aaron |
Chief Financial Officer |
167,128 |
2025-03-07 |
|
| 10 |
Baker Brothers Life Sciences Lp |
Director |
69,290 |
2022-06-24 |
|
| 11 |
Glazer Donald W. |
Director |
34,151 |
2024-06-07 |
|
| 12 |
Malley Thomas |
Director |
26,975 |
2023-06-20 |
|
| 13 |
Dugan Margaret |
Director |
22,750 |
2025-05-22 |
|
| 14 |
Yi Qingqing |
Director |
22,750 |
2025-05-23 |
|
| 15 |
Hooper Anthony C |
Director |
22,750 |
2025-05-22 |
|
| 16 |
Riva Alessandro |
Director |
22,750 |
2025-05-22 |
|
| 17 |
Brandicourt Olivier |
Director |
22,750 |
2025-05-22 |
|
| 18 |
Sanders Corazon (corsee) D. |
Director |
22,750 |
2025-05-22 |
|
| 19 |
Sharp Shalini |
Director |
19,136 |
2025-05-22 |
|
| 20 |
Ball Titus B. |
Principal Accounting Officer |
15,340 |
2024-06-07 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2025-05-21 |
Yi Qingqing |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
| 2025-05-21 |
Dugan Margaret |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
| 2025-05-21 |
Riva Alessandro |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
| 2025-05-21 |
Sanders Corazon (corsee) D. |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
| 2025-05-21 |
Brandicourt Olivier |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
| 2025-05-21 |
Sharp Shalini |
Director |
RSU Award |
10,985 |
- |
- |
| 2025-05-21 |
Hooper Anthony C |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
| 2025-05-13 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
200 |
$225.68 |
$45.14K |
| 2025-05-09 |
Oyler John |
Chief Executive Officer |
Option Exercise (Sell) |
4,055,415 |
$0.50 |
$2.03M |
| 2025-04-14 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
365 |
$249.45 |
$91.05K |
